The marketing of medicinal products in over 100 countries involves a rigorous und updated follow-up of the global Regulatory Affairs activity.
The international Regulatory Affairs department of a global pharmaceutical leader.
Monitoring, enriching and validating a centralized database dedicated to following the Regulatory Affairs activity of the Industrial entity with the authorities of more than 100 countries.
In accordance with the rules implemented by the client, entering the data of diverse documents (sent mails, official documents received from the health authorities, activity reports received from the international Regulatory Affairs contacts of the client…) into the follow-up database.
Archiving the documents according to the procedures implemented by the client.
Quality Doubts Mean EMA to Revisit XEVMPD, Putting Responsibility Back on Industry
Regulatory Information Management Survey of 37 Companies Finds Call for Innovation and Solution Modernisation
9 December Dutch Life Science Conference in Oss, The Netherlands